688265: Announcement on the results of the initial public offering of shares by Nanmo biology and its listing on the science and Innovation Board

Shanghai Nanfang model Biotechnology Co., Ltd

Initial public offering and listing on the science and Innovation Board

Announcement of issuance results

Sponsor (lead underwriter): Haitong Securities Company Limited(600837)

hot tip

The application of Shanghai Nanfang model Biotechnology Co., Ltd. (hereinafter referred to as "Nanmo biology", "issuer" or "company") for the initial public offering of RMB common shares (A shares) (hereinafter referred to as "this offering") has been examined and approved by the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange, and has been approved by the China Securities Regulatory Commission (hereinafter referred to as "China Securities Regulatory Commission") "CSRC") agrees to register (zjxk [2021] No. 3469). The sponsor and lead underwriter of this offering are Haitong Securities Company Limited(600837) (hereinafter referred to as " Haitong Securities Company Limited(600837) " or "sponsor (lead underwriter)"). The issuer's shares are referred to as "Nanmo biology", the expansion is referred to as "Nanmo biology", and the stock code is 688265.

This issuance adopts directional placement to strategic investors (hereinafter referred to as "strategic placement"), offline inquiry placement to qualified offline investors (hereinafter referred to as "offline issuance") and online pricing issuance to social public investors holding the market value of non restricted A-Shares and non restricted depositary receipts in Shanghai market (hereinafter referred to as "online issuance") )Combined. Issuer and sponsor (lead underwriter) comprehensively considering the fundamentals of the issuer, the number of shares issued in this public offering, the industry of the issuer, the valuation level of comparable listed companies, market conditions, demand for raised funds and underwriting risks, the price of this offering is 84.62 yuan / share, and the number of shares issued is 1949.09 million, all of which are new shares without transfer of old shares.

The initial strategic placement quantity of this issuance is 2923635 shares, accounting for 15% of this issuance quantity. The subscription funds promised by the strategic investors have been fully remitted to the bank account designated by the sponsor (lead underwriter) within the specified time. The final strategic placement quantity of this issuance is 1033005 shares, accounting for 5.30% of the total issuance. The difference between the final strategic placement quantity and the initial strategic placement quantity of 1890630 shares has been transferred back to offline issuance.

Before the launch of the online and offline call back mechanism, the number of offline shares issued was 13487895, accounting for 73.07% of the number issued after deducting the final strategic placement; The number of shares issued online was 4.97 million, accounting for 26.93% of the number issued after deducting the final strategic placement.

According to the callback mechanism announced in the announcement of Shanghai Southern model Biotechnology Co., Ltd. on initial public offering of shares and listing on the science and Innovation Board (hereinafter referred to as the "issuance announcement"), as the initial effective subscription multiple of online investors is 4438.16 times, more than 100 times, the issuer and the sponsor (the lead underwriter) decided to start the callback mechanism, adjust the scale of offline and online issuance, and callback 1846000 shares from offline to online. After the callback mechanism was started, the final number of offline issuance was 11641895 shares, accounting for 63.07% of the number of issuance after deducting the number of strategic placement, and the final number of online issuance was 6816000 shares, accounting for 63.07% of the number of issuance after deducting the number of strategic placement 36.93% of the issued quantity.

After the callback mechanism was launched, the final winning rate of online issuance was 0.03090081%.

The online and offline subscription and payment of this offering has been completed on December 21, 2021 (T + 2). I. statistics of new share subscription

The sponsor (lead underwriter) has made statistics on the subscription of new shares issued online and offline according to the data provided by Shanghai Stock Exchange and China Clearing Shanghai Branch. The results are as follows:

(i) Strategic placement

The strategic placement of this issuance consists of the follow-up investment of relevant subsidiaries of the sponsor, the senior management and core employees of the issuer participating in the special asset management plan established by this strategic placement, The follow-up investment institution is Haitong innovation Securities Investment Co., Ltd. (hereinafter referred to as "Haitong venture capital"), the senior management and core employees of the issuer participate in the special asset management plan established by this strategic placement, and the employees of Fucheng Haifutong Nanmo biology participate in the integrated asset management plan of strategic placement on the science and innovation board.

As of December 14, 2021 (T-3), all strategic investors have paid the subscription funds and the corresponding new share placement brokerage commission in full and on time (Haitong venture capital does not need to pay the new share placement brokerage commission). The recommendation institution (lead underwriter) has been established on December 23, 2021 Before (T + 4 day), return the excess amount of the initial payment of the strategic investor exceeding the corresponding amount of the final allocated shares.

The subscription results of strategic investors are as follows:

No. number of shares allocated to investors amount allocated (yuan, restricted period of new share placement broker (shares) excluding Commission) Commission (yuan) (month)

1 Haitong Chuangxin Securities Investment Co., Ltd. 709052599980.24024

2 employee reference of Fucheng Haifutong Nanmo biology 32395327412902.86137064.5112

Strategic placement of collective assets with Kechuang board

management plan

Total 103300587412883.10137064.51-

(2) Online subscription of new shares

(1) Number of shares subscribed by online investors (shares): 6696692

(2) Subscription amount paid by online investors (yuan): 566674077.04

(3) Number of online investors giving up subscription (shares): 119308

(4) Subscription amount abandoned by online investors (yuan): 10095842.96

(3) Offline subscription of new shares

(1) Number of shares subscribed by offline investors (shares): 11641895

(2) Subscription amount paid by offline investors (yuan): 985137154.90

(3) Number of offline investors giving up subscription (shares): 0

(4) Subscription amount waived by offline investors (yuan): 0.00

(5) Brokerage commission for placement of new shares paid by offline investors (yuan): 4925688.93

2、 Offline placement lottery results

According to the announcement on IPO arrangement and preliminary inquiry of Shanghai Southern model Biotechnology Co., Ltd. and the announcement on IPO of Shanghai Southern model Biotechnology Co., Ltd. and listing on the science and innovation board, The issuer and the recommendation institution (lead underwriter) on December 22, 2021 On the morning of (T + 3), we presided over the lottery winning ceremony for the online lower limit sale account of Nanmo biology's initial public offering at the Haitang hall on the fourth floor of Zijinshan Hotel, 778 Dongfang Road, Pudong, Shanghai. The lottery ceremony was conducted in accordance with the principles of openness, fairness and impartiality. The lottery process and results have been notarized by Shanghai Dongfang notary office. The winning results are as follows:

Last digit winning lot number

Last "1" digit 8

Last "4" digits 3026

Securities investment funds and other partial stock asset management products established by participating in the public offering of offline issuance and subscription of A-Shares of Nanmo biology, national social security fund, basic endowment insurance fund, enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund If the mantissa of the subscription allotment number held by the placement objects such as insurance funds and QFII funds that meet the relevant provisions of the measures for the administration of the use of insurance funds is the same as the above number, it is the winning number. A total of 3932 accounts participated in offline placement and lottery in this issuance, 10% of the final allocated account (rounded up) the corresponding number of accounts is 394. According to the lottery results, the restricted period for all the winning accounts to obtain the shares for this placement is 6 months. The number of shares corresponding to this part of accounts is 834616 shares, accounting for 7.17% of the total offline issuance and 4.52% of the total public issuance after deducting the number of strategic placements. The placing pairs won this online lottery are For details, please refer to the "attached table: lottery results of offline placement".

3、 Underwriting by the sponsor (lead underwriter)

The number of shares abandoned by online and offline investors is underwritten by the sponsor (lead underwriter). The number of shares underwritten by the sponsor (lead underwriter) is 119308 shares, and the underwriting amount is 10095842.96 yuan. The number of shares underwritten by the sponsor (lead underwriter) accounts for 0.61% of the total amount of this offering.

December 23, 2021 (T + 4), sponsor (lead underwriter) in accordance with the recommendation and underwriting agreement, transfer the remaining underwriting funds, the funds raised from strategic placement and the funds raised from offline and online issuance together with the recommended underwriting fee and the brokerage commission for new share placement to the issuer. The issuer submits a share registration application to China Clearing Shanghai Branch and registers the underwritten shares in the securities account designated by the recommendation institution (lead underwriter).

4、 Contact information of sponsor (lead underwriter)

If online and offline investors have any questions about the issuance results announced in this announcement, please contact the sponsor (lead underwriter) of this issuance.

Contact details are as follows:

Tel: 021-23219622, 021-23219496, 021-23219524, 021-23219904 contact: capital market department

Issuer: sponsor (lead underwriter) of Shanghai Nanfang model Biotechnology Co., Ltd.: Haitong Securities Company Limited(600837) December 23, 2021 (there is no text on this page, which is the seal page of the announcement on the results of initial public offering and listing on the science and Innovation Board of Shanghai Nanfang model Biotechnology Co., Ltd.)

Issuer: Shanghai Nanfang model Biotechnology Co., Ltd. (this page has no text and is the seal page of the announcement on the results of initial public offering and listing on the science and Innovation Board of Shanghai Nanfang model Biotechnology Co., Ltd.)

Sponsor (lead underwriter): Haitong Securities Company Limited(600837) mm / DD / yy

Attached table: lottery results of offline placement

The placing object is finally obtained

No. offline investor name placing object name code number placing period (shares)

1 China Europe Fund Management Co., Ltd. China Europe foreseeable pension target date 2035 three-year holding period mixed d89014927923746 months fund in combined fund

2 Europe Fund Management Co., Ltd. China Europe electronic information industry Shanghai Hong Kong Shenzhen stock securities investment d89009154923746 month fund

3 China Europe Fund Management Co., Ltd. China Europe times Pioneer stock sponsored securities investment fund d89002628523746 months

4 China International Capital Corporation Limited(601995) enterprise annuity plan of China Railway Guangzhou Bureau Group Co., Ltd. b88242190523746 months

5 China International Capital Corporation Limited(601995) Zhongjin Fengda stock pension product b88354467019786 months

6 China International Capital Corporation Limited(601995) Henan No. 9 occupational pension plan b88347874815836 months

7 China International Capital Corporation Limited(601995) Shanghai No. 1 occupational pension plan b88283243623746 months

8 China International Capital Corporation Limited(601995) Jiangsu No. 2 occupational pension plan b88289096323746 months

 

- Advertisment -